In this module, we introduce you to hypoglycaemia, starting with a brief survey of its epidemiology and significance, followed by a look at three principal ways of addressing the problem: new insulins, new technologies and structured education and training.
By the end of this module, you will be able to:
✓ Appraise the RCT and real-world data on insulin analogues and ultra long-acting insulin analogues and their effects on reducing hypoglycaemia in type 1 and type 2 diabetes
✓ Explain the potential for new technology to help reduce hypoglycaemia, including flash monitoring, real-time continuous glucose monitoring and the artificial pancreas in type 1 and type 2 diabetes
✓ Examine the role of education and training in addressing the problems of hypoglycaemia in type 1 and type 2 diabetes
This module includes self-marked assessments, such as knowledge checks and/or case studies, as well as a marked final assessment, which you can attempt up to five times. To complete the module, you must review all chapters, pass the final assessment (80% pass mark), and fill in our feedback form.